Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement. Issue 23 (29th August 2019)

• Record Type: Journal Article
• Authors: Singh, Anvesha; Musa, Tarique Al; Treibel, Thomas A; Vassiliou, Vassiliou S; Captur, Gabriella; Chin, Calvin; Dobson, Laura E; Pica, Silvia; Loudon, Margaret; Malley, Tamir; Rigolli, Marzia; Foley, James Robert John; Bijsterveld, Petra; Law, Graham R; Dweck, Marc Richard; Myerson, Saul G; Prasad, Sanjay K; Moon, James C; Greenwood, John P; McCann, Gerry P
• Is Part Of: Heart. Volume 105:Issue 23(2019)
• Page Start: 1818
• Page End: 1824
• Publication Date: 2019-08-29
• Subjects: aortic stenosis -- AVR -- CMR; Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2019-314987
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Objectives: To investigate sex differences in left ventricular remodelling and outcome in patients undergoing surgical or transcatheter aortic valve replacement (SAVR/TAVR). Methods: In this multicentre, observational, outcome study with imaging core-lab analysis, patients with severe aortic stenosis (AS) listed for intervention at one of six UK centres were prospectively recruited and underwent cardiovascular magnetic resonance imaging. The primary endpoint was all-cause mortality and secondary endpoint was cardiovascular mortality. Results: 674 patients (425 men, 249 women, age 75±14 years) were included: 399 SAVR, 275 TAVR. Women were older, had higher surgical risk scores and underwent TAVR more frequently (53% vs 33.6%, p<0.001). More men had bicuspid aortic valves (BAVs) (26.7% vs 14.9%, p<0.001) and demonstrated more advanced remodelling than women. During a median follow-up of 3.6 years, 145 (21.5%) patients died, with no significant sex difference in all-cause mortality (23.3% vs 20.5%, p=0.114), but higher cardiovascular mortality in women (13.7% vs 8.5%, p=0.012). There were no significant sex-related differences in outcome in the SAVR or TAVR subgroups, or after excluding those with BAV. Factors independently associated with all-cause mortality were age, left ventricular ejection fraction (LVEF), BAV (better) and myocardial fibrosis detected with late gadolinium enhancement (LGE) in men, and age, LVEF and LGE in women. Age and LGE were independently associated with cardiovascular mortality in both sexes. Conclusions: Men demonstrate more advanced remodelling in response to a similar severity of AS. The higher cardiovascular mortality observed in women following AVR is accounted for by women having less BAV and higher risk scores resulting in more TAVR. LGE is associated with a worse prognosis in both sexes.